Blood-based metabolic signatures in Alzheimer's disease
Authors:
- Francisca A. de LeeuwFLFrancisca A. de Leeuw
- Carel F. W. PeetersCPCarel F. W. Peeters
- Maartje I. KesterMKMaartje I. Kester
- Amy C. HarmsAHAmy C. Harms
- Eduard A. StruysESEduard A. Struys
- Thomas HankemeierTHThomas Hankemeier
- Herman W. T. van VlijmenHVHerman W. T. van Vlijmen
- Sven J. van der LeeSLSven J. van der Lee
- Cornelia M. van DuijnCDCornelia M. van Duijn
- Philip ScheltensPSPhilip Scheltens
- Ayşe DemirkanADAyşe Demirkan
- Mark A. van de WielMWMark A. van de Wiel
Preprint
Abstract
Introduction: Identification of blood-based metabolic changes might provide early and easy-to-obtain biomarkers. Methods: We included 127 AD patients and 121 controls with CSF-biomarker-confirmed diagnosis (cut-off tau/A$\beta_{42}$: 0.52). Mass spectrometry platforms determined the concentrations of 53 amine, 22 organic acid, 120 lipid, and 40 oxidative stress compounds. Multiple signatures were assessed: differential expression (nested linear models), classification (logistic regression), and regulatory (network extraction). Results: Twenty-six metabolites were differentially expressed. Metabolites improved the classification performance of clinical variables from 74% to 79%. Network models identified 5 hubs of metabolic dysregulation: Tyrosine, glycylglycine, glutamine, lysophosphatic acid C18:2 and platelet activating factor C16:0. The metabolite network for APOE $\epsilon$4 negative AD patients was less cohesive compared to the network for APOE $\epsilon$4 positive AD patients. Discussion: Multiple signatures point to various promising peripheral markers for further validation. The network differences in AD patients according to APOE genotype may reflect different pathways to AD.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysisAlzheimer's & Dementia, 2016
- A UHPLC–TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse modelJournal of Pharmaceutical and Biomedical Analysis, 2015
- Behavioral and cognitive effects of tyrosine intake in healthy human adultsPharmacology Biochemistry and Behavior, 2015
- Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's diseaseJournal of Pharmaceutical and Biomedical Analysis, 2015
- Discriminatory and predictive capabilities of enzyme‐linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease studyAlzheimer's & Dementia, 2012
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosisMetabolomics, 2011
- Quantitative metabolomics based on gas chromatography mass spectrometry: status and perspectivesMetabolomics, 2010
- Metabolic Phenotyping in Health and DiseaseCell, 2008
- Graph drawing by force‐directed placementSoftware: Practice and Experience, 1991